传统观念认为哮喘是支气管平滑肌痉挛,气道狭窄所致,治疗以支气管扩张剂为主;而近10多年来的研究表明:哮喘是一种以嗜酸粒细胞、肥大细胞反应为主的气道慢性炎症,因此其治疗重心也从缓解支气管平滑肌痉挛转向控制气道炎症。皮质激素是强有力的哮喘抗炎药物,β2受体激动剂是常用 The traditional concept that asthma is bronchial smooth muscle spasm, airway stenosis, the treatment of bronchodilators based; and nearly 10 years of research have shown that: asthma is a eosinophil, mast cell-based airway Chronic inflammation, so its treatment center of gravity also from the bronchial smooth muscle spasm shift control airway inflammation. Corticosteroids are potent asthma anti-inflammatory drugs, and beta 2 receptor agonists are commonly used